← Back to Home

Phanes Therapeutics

Private
#Oncology#Biliary tract cancer#Immunotherapy

Phanes Therapeutics is a clinical-stage biotechnology company focused on innovative drug discovery and development in oncology. Recently expanded its clinical trial collaboration with Merck to evaluate spevatamig in combination with KEYTRUDA for biliary tract cancer.

Company Info

Sector:Oncology
Headquarters:San Diego, California, USA
Founded:2018
Website:www.phanesthera.com/

Upcoming Milestones & Key Dates

Q4 2026
Clinical

Phase 2 interim readout

Clinical Development Pipeline

Spevatamig

Target: PD-L1/CD55
Biliary tract cancer
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Undisclosed

Target: TBD
Solid tumors
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Undisclosed

Target: TBD
Hematologic malignancies
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Recent News

Leadership Team

To be confirmed

Chief Executive Officer

To be confirmed

Chief Medical Officer

To be confirmed

Chief Scientific Officer

Careers & Job Openings

See all open roles

Various
San Diego, CA
Apply Now →